Cocrystal Historical Cash Flow
| COCP Stock | USD 1.88 0.10 5.05% |
Analysis of Cocrystal Pharma cash flow over time is an excellent tool to project Cocrystal Pharma future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 39.1 M or Other Cashflows From Financing Activities of 0.0 as it is a great indicator of Cocrystal Pharma ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Cocrystal Pharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cocrystal Pharma is a good buy for the upcoming year.
Cocrystal |
About Cocrystal Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Cocrystal balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cocrystal's non-liquid assets can be easily converted into cash.
Cocrystal Pharma Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Cocrystal Pharma's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's Stock Based Compensation is relatively stable compared to the past year. As of 12/11/2024, Sale Purchase Of Stock is likely to grow to about 43.2 M, while Other Non Cash Items is likely to drop slightly above 1.5 M.
Cocrystal Pharma cash flow statement Correlations
Click cells to compare fundamentals
Cocrystal Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cocrystal Pharma cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 4.7M | 25.6M | 25.7M | (21.5M) | (10.8M) | (10.3M) | |
| Free Cash Flow | (1.7M) | (10.1M) | (12.8M) | (21.5M) | (14.8M) | (14.0M) | |
| Change In Working Capital | 443K | (878K) | 796K | (2.7M) | 2.3M | 2.5M | |
| Begin Period Cash Flow | 2.8M | 7.5M | 33.1M | 58.8M | 37.2M | 39.1M | |
| Other Cashflows From Financing Activities | 1.2M | 6.4K | (240K) | (52K) | (74K) | 0.0 | |
| Other Non Cash Items | (133K) | (177K) | (195K) | 18.9M | 1.6M | 1.5M | |
| Capital Expenditures | 145K | 240K | 52K | 74K | 118K | 132.9K | |
| Total Cash From Operating Activities | (1.6M) | (9.8M) | (12.7M) | (21.4M) | (14.7M) | (13.9M) | |
| Net Income | (48.2M) | (9.6M) | (14.2M) | (38.8M) | (18.0M) | (18.9M) | |
| Total Cash From Financing Activities | 6.4M | 35.7M | 38.5M | (27K) | 4.0M | 7.7M | |
| End Period Cash Flow | 7.5M | 33.1M | 58.8M | 37.2M | 26.4M | 27.7M | |
| Depreciation | 98K | 157K | 190K | 388K | (1.4M) | (1.3M) | |
| Stock Based Compensation | 351K | 662K | 724K | 855K | 801K | 1.5M | |
| Sale Purchase Of Stock | 711K | 7.9M | 6.6M | 35.8M | 41.2M | 43.2M | |
| Net Borrowings | (214K) | (121K) | (39K) | (27K) | (24.3K) | (23.1K) | |
| Cash And Cash Equivalents Changes | (2.9M) | 2.0M | 4.7M | 25.6M | 29.4M | 30.9M | |
| Change To Netincome | 46.2M | 539K | 480K | 19.7M | 22.7M | 23.7M | |
| Change To Liabilities | 919K | (919K) | 217K | (1.0M) | (933.3K) | (886.6K) | |
| Investments | (145K) | (240K) | (52K) | (74K) | (71K) | (67.5K) | |
| Total Cashflows From Investing Activities | (145K) | (240K) | (52K) | (74K) | (66.6K) | (63.3K) | |
| Cash Flows Other Operating | (6.5M) | (13.6M) | 35K | (224K) | (257.6K) | (270.5K) | |
| Change To Operating Activities | 12K | (226K) | (169K) | (1.7M) | (1.5M) | (1.4M) | |
| Issuance Of Capital Stock | 6.6M | 35.8M | 38.5M | 4M | 3.6M | 3.4M |
Pair Trading with Cocrystal Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cocrystal Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Cocrystal Stock
Moving against Cocrystal Stock
| 0.64 | AMGN | Amgen Inc | PairCorr |
| 0.63 | ABBV | AbbVie Inc | PairCorr |
| 0.6 | TTOO | T2 Biosystms | PairCorr |
| 0.58 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.57 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
The ability to find closely correlated positions to Cocrystal Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cocrystal Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cocrystal Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cocrystal Pharma to buy it.
The correlation of Cocrystal Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cocrystal Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cocrystal Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cocrystal Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cocrystal Stock Analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.